alpha-cyclodextrin (ASDERA)

N/A

Report date: 2025/03/14 16:19:36
NME

Base Information

Drug Namealpha-cyclodextrin (ASDERA)
Drug Alias NameASD-004 (ASDERA)ASD-004
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsdera
China Registration ClassN/A

Develop Information

Active CompaniesAsdera
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A